Prof. Dr. med.François CurtinLeiter Zentrum Klinische Forschung, Luzern

Behandlungsschwerpunkte

• Clinical research methodology
• Design of clinical trials and other clinical studies
• Medical writing (publications, reports, grants)
• Support for thesis (MD, PHD, PD) development
• Regulatory interactions
• Support for funding search and innovation development

Sprachen

Französisch, Englisch, Deutsch

Beruflicher Werdegang

• Since Sept. 2023: Leiter Zentrum für Klinische Forschung LUKS
• Since 2020: Medical Director Personalized Health Programs at ETH Zürich
• Since 2022: Titular Professor Unige/HUG Department of Clinical Pharmacology and Toxciology, co-director of DAS Management of Clinical Trials and MAS Drug Discovery and Clinical Development
• 2009 - 2020: General manager and medical director, Geneuro SA, biotech active in development of monoclonal antibodies for auto-immune disorders
• 2003 - 2009: Executive positions in clinical and business development, Serono SA and Merck KgaA
• 2001 - 2003: Senior Clinical Assessor, Swissmedic
• 1989 - 2000: Clinical and research positions at HUG-Genève and London School of Hygiene and Tropical Medicine

Aus-/Weiterbildung und Diplome

• 2006: MBA, Warwick University
• 2003: Habilitation, University of Geneva
• 1999: Master of Philosophy in Medical Statistics, University of London
• 1990: Doctorate in Medicine. University of Geneva
• 1989: Swiss Federal Diploma of Medicine, University of Geneva

Mitgliedschaft in Fachgesellschaften

• Swiss Society of Clinical Pharmacology and Toxicology
• Royal Statistical Society
• British Association of Psychopharmacology